New deep-learning framework identifies non-addictive pain relief options

FHS
October 7, 2024
10:57 am

An estimated one in five Americans live with chronic pain and current treatment options leave much to be desired.

Next-generation sequencing and machine learning used to map genetic landscape of pancreatic cancer

A new research paper was published in Oncotarget’s Volume 15 on February 5, 2024, entitled, “Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas: next-generation

February 16, 2024

Trial Supports GLP-1 After Underwhelming Metabolic Surgery

Adding a GLP-1 receptor agonist to lifestyle intervention helped to bolster weight loss in patients with poor outcomes following primary metabolic surgery, the BARI-OPTIMISE randomized

July 28, 2023

Updated: Oculis closes Phase 3 eye drop trial due to ‘administrative error’ from third party

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.